chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt the sting or prick travel down to her hand and felt a little sting and jerked a little; the middle section of the middle finger was a little bit red; Her right arm is black and blue and swollen; pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt the sting or prick travel down to her hand and felt a little sting and jerked a little), ERYTHEMA (the middle section of the middle finger was a little bit red), SKIN DISCOLOURATION (Her right arm is black and blue and swollen) and PAIN (pain) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (felt the sting or prick travel down to her hand and felt a little sting and jerked a little), ERYTHEMA (the middle section of the middle finger was a little bit red), SKIN DISCOLOURATION (Her right arm is black and blue and swollen) and PAIN (pain). At the time of the report, PAIN (felt the sting or prick travel down to her hand and felt a little sting and jerked a little), ERYTHEMA (the middle section of the middle finger was a little bit red), SKIN DISCOLOURATION (Her right arm is black and blue and swollen) and PAIN (pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient got the first dose of the Moderna vaccination in her right arm at the hospital with lot number 011A21A. When she received the injection, she felt the sting or prick travel down to her hand and felt a little sting and jerked a little. When she looked at her hand and the middle section of the middle finger was a little bit red. She chose not to receive the vaccine in her left arm as she has a more serious and pins and needles sensation in that arm. She states her right arm has a little bit of arthritis. Her right arm is black and blue and swollen. Patient used cold compress for the pain.
bilateral hives with welts extending up both sides of the neck, chest, abdomen and spreading to the back 20mg Loratidine taken 2 hours from onset, continued 10mg/12hrs for the next 3 days rx epipen, not taken hives reduced over the next 2 days
This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (restart vaccination series Dose 1: Aug 9 2021, Restart: Dec 16 2021) and OFF LABEL USE (My doctor wanted me to start all over again, I restarted on Dec 16 2021) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069HZ1A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for Diabetes, PIROXICAM (PAXIL [PIROXICAM]) and OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE; PARACETAMOL]) for an unknown indication. On 16-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (restart vaccination series Dose 1: Aug 9 2021, Restart: Dec 16 2021) and OFF LABEL USE (My doctor wanted me to start all over again, I restarted on Dec 16 2021). On 16-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (restart vaccination series Dose 1: Aug 9 2021, Restart: Dec 16 2021) and OFF LABEL USE (My doctor wanted me to start all over again, I restarted on Dec 16 2021) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment information mentioned. Patient could not remember other medications. The patient got her Moderna shot on 9-Aug-2021, after that she had a heart attack. She could not got her second dose, as she was in hospital in coma. Her doctor wanted her to start all over again, she restarted on 16-Dec-2021. This case was linked to MOD-2022-447503 (Patient Link).
30 to 35 mins after the injection he experienced redness and itchiness on the injection site; 30 to 35 mins after the injection he experienced redness and itchiness on the injection site, his; 30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach; 30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (30 to 35 mins after the injection he experienced redness and itchiness on the injection site), INJECTION SITE ERYTHEMA (30 to 35 mins after the injection he experienced redness and itchiness on the injection site, his), PRURITUS (30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach) and ERYTHEMA (30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL, BENAZEPRIL, AMLODIPINE and METFORMIN for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced INJECTION SITE PRURITUS (30 to 35 mins after the injection he experienced redness and itchiness on the injection site), INJECTION SITE ERYTHEMA (30 to 35 mins after the injection he experienced redness and itchiness on the injection site, his), PRURITUS (30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach) and ERYTHEMA (30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach). On 02-Mar-2021, INJECTION SITE PRURITUS (30 to 35 mins after the injection he experienced redness and itchiness on the injection site), INJECTION SITE ERYTHEMA (30 to 35 mins after the injection he experienced redness and itchiness on the injection site, his), PRURITUS (30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach) and ERYTHEMA (30 to 35 mins after the injection he experienced redness and itchiness on his right hand, his neck and stomach) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       consent to follow up with safety YES
I got my second vaccine on Friday January 15, 2021. On the following Monday (January 18), I started having chest pain around 5:00 pm before leaving work. The chest pain got worse until I woke up in the middle of the night afraid I was having a heart attack and vomiting. I got up and planned to go to the hospital at  around 5 am but the pain started to subside. I made an appointment to see my PCP the following Friday (January 22nd) and had cardiac labs drawn. My heart enzymes were elevated that day so my PCP chose to admit me into the hospital. I had a heart cath, wore a heart monitor, had EKGs, had my enzymes trended, and had a heart ultrasound. The cardiologist discharged me with possible myocarditis. I took a regimen of ibuprofen and symptoms subsided. I had been having chest pain off and on for about a month before this episode but thought it was heart burn because it was very mild.
This case was reported by a physician via sales rep and described the occurrence of myalgia in a 62-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included dTpa vaccine for prophylaxis. On 21st May 2018, the patient received SHINGRIX and dTpa vaccine. On an unknown date, less than a month after receiving SHINGRIX and dTpa vaccine, the patient experienced myalgia, vertigo positional, fatigue and pain localized. On an unknown date, the outcome of the myalgia, vertigo positional, fatigue and pain localized were unknown. It was unknown if the reporter considered the myalgia, vertigo positional, fatigue and pain localized to be related to SHINGRIX and dTpa vaccine. Additional details were provided as follows: The patient reported the feeling of normal myalgia, fatigue and local pain as indicated in the PI and cleared up in 1 to 2 days but also reported a positional vertigo which was persisted for 3 weeks since vaccination. The reporter would like to discuss with GlaxoSmithKline if this patient should receive the 2nd dose or not.
For the first day or two after receiving the vaccine I experienced injection site soreness, fatigue and malaise, and sore throat. Symptoms resolved within 2-3 days and I was symptom free by the time I went back to work on 12/24
I had sore for three days days, then on Monday afternoon I started having difficult breathing, I can?t really work because I?m not breathing properly. It?s been like this for 4 days. I?m not sure if this is a an allergic reaction like it says or something serious. I?m going to the doctor tomorrow and see if something is wrong with my lungs because I get panic attacks cause I can?t breath.
On Jan 5th she developed welts, swelling and a rash at the injection site. Today there is still slight itching rash. She was also VERY fatigued after the rash started. Today the fatigue is better.
On April 29th, 2021, the client had a Pfizer first dose taken from LACVP. Due to not being able to find an option to get a second dose of Pfizer, the client chose the option of taking the second mRNA type vaccine of Moderna as the second dose.
Information regarding Prevnar was received from a consumer, the mother of an 8 week old male patient who received a first dose on 6/17/03. The patient also received a first dose of Tripedia, Act-HIB, and Polio vaccine on the same day, and was reported to have slept a lot post vaccination. The patient's concurrent illness includes haematochezia (suspected diary product allergy). Indication for Prevnar was immunization. Product was administered on 6/17/03. Dose regimen was 0.5ml 1 time per day (IM). Patient was not taking concomitant therapy. On 6/17/03, an 8 week old male patient received his first dose of Prevnar, Tripedia, Act-HIB, and IPOL. His mother reported that the slept a lot for a day or so following his first shot. Information regarding this event has been forwarded to the manufacturer of the concomitantly administered vaccines. No additional information was available at the time of this report.
Pt fainted during the 15 minute waiting period. Hit head. Recovered quickly. Was evaluated by rescue squad.
Anxiety, feelings of impending doom (similar to someone having a heart attack); flu like symptoms; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety, feelings of impending doom (similar to someone having a heart attack)), INFLUENZA LIKE ILLNESS (flu like symptoms) and VACCINATION SITE PAIN (vaccination site pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced ANXIETY (Anxiety, feelings of impending doom (similar to someone having a heart attack)), INFLUENZA LIKE ILLNESS (flu like symptoms) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, ANXIETY (Anxiety, feelings of impending doom (similar to someone having a heart attack)), INFLUENZA LIKE ILLNESS (flu like symptoms) and VACCINATION SITE PAIN (vaccination site pain) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  No Relevant concomitant medications was reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-109482 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109482:Husbands case
Received an Engerix-B dose that had expired; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 50-year-old female patient who received HBV (Engerix B) (batch number 2NK52, expiry date 28th February 2021) for prophylaxis.   On 10th July 2021, the patient received Engerix B. On 10th July 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were reported as follows: On 10th July 2021, patient received a dose of Engerix B, which was expired on February 2021. The reporter consented to follow up.
Left leg pain, tingling,  weakness, and swelling.   Heart palpitations. Stabbing discomfort in chest.
After 12 hours experienced severe chills, very low grade fever, sleeplessness, fatigue, lasted for about 12 hours.  Several weeks after the 2nd dose of Moderna vaccine, I have noticed a marked increase in my Tinnitis.  comes and goes at al l hours of the day and sometime at night.
diarrhea; tired; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (diarrhea) and FATIGUE (tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B22A, 048C21A, 047B21A and 046A21A) for COVID-19 vaccination.     The patient had no allergies. The patient did not have COVID positive test or diagnosis.  Concurrent medical conditions included Skin disorder NOS (history of skin, many years before the 1st dose of Moderna vaccine) and Blood pressure abnormal (history of blood pressure many years before the 1st dose of Moderna vaccine). Concomitant products included HYDROCHLOROTHIAZIDE and ATENOLOL for Blood pressure abnormal, METHOTREXATE for Skin disorder NOS.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and FATIGUE (tired). At the time of the report, DIARRHOEA (diarrhea) and FATIGUE (tired) outcome was unknown.            The patient reported that 3 days later, after receiving the 2nd booster she had diarrhea and was tired. The patient also reported that she did not have any other side effects.   The patient reported that she had a mammogram scheduled on 15-Aug-2022.   The patient did not receive any treatment for the events.
This spontaneous report as received from a physician refers to a female patient of unknown age who on an unknown date, was vaccinated with a dose of ZOSTAVAX (dose and route not reported). It was reported that 1 to 2 weeks later on an unknown date, the patient experienced itchiness and tingling. The physician did not diagnose the rash as shingles as it had unusual appearance more like poison ivy, unlike what she was familiar with seeing for shingles. The physician prescribed acyclovir. The patient returned in two weeks on an unspecified date, and the rash had spread across the entire trunk area, although the area that had been treated was not pronounced. The patient was recovering. Prior to administering the ZOSTAVAX was inquiry on whether the patient had chickenpox from the physician and the initially answer was yes. Now the patient was not sure. The relatedness for rash like poison ivy, itchiness and tingling and ZOSTAVAX was unknown. Additional information has been requested.
it was noticed that this patient was given the flu vaccine on october 4th but she was also given the flu vaccine on 10/27 /22 , protocol was followed
Fever T 100.1, also expose to covid + husband within the last 5 days without mask
inadvertently received BOOSTRIX on November 7, 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-day-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 7C75N, expiry date 06-DEC-2025) for prophylaxis.   On 07-NOV-2023, the patient received Boostrix. On 07-NOV-2023, an unknown time after receiving Boostrix, the patient experienced inappropriate age at vaccine administration (Verbatim: inadvertently received BOOSTRIX on November 7, 2023). The outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK Receipt Date: 07-NOV-2023 The reporter was a pharmacist.   The pharmacist reported that an infant inadvertently received Boostrix, which led to inappropriate age at vaccination.  The reporter consented to follow up.
Numbness feet with progression - intubated - Guillain-Barre - unable to manage secretions.  11/23/10 patient currently admitted to ICU.
pt recvd vax 20FEB96 & same day aunt reported pt exp a sz (eyes rolled back, acted like wanted to swallow tongue, walked up to aunt & patted aunt on leg;leg where vax given was sore;
The pt received the first and second injections of Lymerix in September and October 1999, respectively. The pt had no adverse experiences following the receipt of these two injections. She received her third injection of Lymerix in November 2000. In November 2000, an unspecified time after receiving the third injection, the pt began to experience fatigue. In November 2000 or December 2000, she began to experience "muscle pain all over". In February 2001, she began to experience bone pain and could not move her right arm or her neck. She was seen by her physician who reportedly prescribed massage therapy; this was not effective. In March or April 2001 the pt began to experience stiffness in her left ankle, left knee and left elbow. She also experienced back pain that radiated to both legs, pain that "would travel from "joint to joint", and night sweats. Her symptoms persisted and she was seen by her physician on 07/03/2001. The pt reported that a diagnosis of Lyme disease was made and three weeks of unspecified antibiotics was prescribed. She reported that her symptoms persisted as of 07/16/2001.
Reported to primary care office that she developed a rash on the left arm after receiving the 1st dose of the Pfizer vaccine. Administered 11/28 and rash started on 11/29.
After two days of whole-body fatigue, a large red welt that is firm and hot to the touch started growing around the injection site. It is currently about the size of a baseball.
Temp 105 degrees F for 3 days, left arm paralysis for one day. Swelling, redness for 4 days, loss of hearing in left ear. Flu symptoms. Extreme pain left arm. Swelling of lymph glands.
Presented with AMS, + Covid ED; Admit 9/15 medical with Covid PNA; tx 9/15 maxipime, steroids, LMWH, zince started  9/16 remdesivir started,  9/18 singulair started; Minimal supplemental O2 required; back to RA at time of D/D
10-28-10 - arm numb, large lump under right arm Tx with KEFLEX & BACTRIM X 10 days - 10-29-10- Ped. on-call 11-1-10 - ultra sound 11-5-10 - biopsy - tissue showed (+) flu vaccine 11-9-10 - antibiotics d'c: pt continues with diarrhea & vomiting referred Ped Inf Disease M.D.
pt recv vax 1FEB96 & 6DEC96 pt devel @ least 150 lesions from scalp to toes, including the palms of hands, trunk & ears;pt MD recommended colloidal oatmeal (aveeno) & DPh;
Hep B vaccine expired on 1/17/18-vacc was given one day past exp. date. No tx needed. Spoke to employee at Merck and Co. - stated provider discretion on re-vaccination, but potency of vacc should be okay. Patient notified at 12:40 PM
Was given 0.3 ml of undiluted vaccine which was the dose for a 12 year old but she is 11 years old. She did not have any reaction to the dose thus far.
Large, spreading red rash on arm where injection was given. Rash spreads from shoulder to a few inches above the elbow on the outer part of my arm, and all the way to the elbow on the inner part. Itchy, swollen, and painful. It started about 3 days after vaccine. Other side effects were just fever and flu-like symptoms the day after vaccination, and pain at the injection site, until the rash started.
After receiving the vaccine,  my period started two weeks early and with much worse symptoms than usual. More cramps, worse nausea, a heavier flow, more migraines. As I am on birth control, and was only in the second week of it, this was very unusual.
Stroke.  Admitted to ICU and given TPA within 1 hour of symptoms.  Initial symptoms were difficulty speaking and left side paralysis
Syncope and possible seizure activity; after laying down and BP and pulse stabilized, no more seizure activity.  Patient came up agitated and then calmed down.
Immunizations given at 3:30 pm 5/5/04 at 6pm. Fever, lethargy, listlessness, swelling to site of left arm. Slight redness. Fever to 104: called on call nurse service and on call doctor. Encouraged ER visit for flu: tylenol/motrin q 3hours: 5-6-04- continued fever 103 degrees, listlessness.
got the shot / got the shingles/Suspected vaccination failure; got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was reporter's son's father-in-law.                                  The age at vaccination was not reported. The patient did not wanted shingles, so he got Shingle shot and it cost him 400 dollars. The patient got the shingles anyway. The reporter stated that the Shingles shot did not always work. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
I was extremely lethargic; I could barely stand up. I would only get up to go the bathroom and to eat and then go back to bed. I did this day in and day out. I had no fever. I had very severe headaches, I had nausea. I had chills for 3 days straight the worst I have ever had. I had abdominal pain, lower abdominal pain. I went to an urgent care and talked to an NP. They advised that everyone had that vaccine, and they were out that day after. They advised to contact my doctor and to see if I should get the second vaccine. I also had bad joint pain.
Alot of soreness in upper left arm extending down to the middle of arm. Almost uncontrollable fits of crying, visions of past events felt very strongly, loss of concentration,strong  loss of recent events, very strange dreams.